102 related articles for article (PubMed ID: 15150585)
1. Low value of detection of KRAS2 mutations in circulating DNA to differentiate chronic pancreatitis to pancreatic cancer.
Marchese R; Muleti A; Brozzetti S; Gandini O; Brunetti E; French D
Br J Cancer; 2004 Jun; 90(11):2243. PubMed ID: 15150585
[No Abstract] [Full Text] [Related]
2. Differential diagnosis between chronic pancreatitis and pancreatic cancer: value of the detection of KRAS2 mutations in circulating DNA.
Maire F; Micard S; Hammel P; Voitot H; Lévy P; Cugnenc PH; Ruszniewski P; Puig PL
Br J Cancer; 2002 Aug; 87(5):551-4. PubMed ID: 12189555
[TBL] [Abstract][Full Text] [Related]
3. Sensitive and quantitative detection of KRAS2 gene mutations in pancreatic duct juice differentiates patients with pancreatic cancer from chronic pancreatitis, potential for early detection.
Shi C; Fukushima N; Abe T; Bian Y; Hua L; Wendelburg BJ; Yeo CJ; Hruban RH; Goggins MG; Eshleman JR
Cancer Biol Ther; 2008 Mar; 7(3):353-360. PubMed ID: 18075308
[TBL] [Abstract][Full Text] [Related]
4. Low correspondence between K-ras mutations in pancreatic cancer tissue and detection of K-ras mutations in circulating DNA.
Marchese R; Muleti A; Pasqualetti P; Bucci B; Stigliano A; Brunetti E; De Angelis M; Mazzoni G; Tocchi A; Brozzetti S
Pancreas; 2006 Mar; 32(2):171-7. PubMed ID: 16552337
[TBL] [Abstract][Full Text] [Related]
5. Kras mutation analysis of fine needle aspirate under EUS guidance facilitates risk stratification of patients with pancreatic mass.
Maluf-Filho F; Kumar A; Gerhardt R; Kubrusly M; Sakai P; Hondo F; Matuguma SE; Artifon E; Monteiro da Cunha JE; César Machado MC; Ishioka S; Forero E
J Clin Gastroenterol; 2007; 41(10):906-10. PubMed ID: 18090159
[TBL] [Abstract][Full Text] [Related]
6. K-ras mutations in circulating DNA from pancreatic and lung cancers: bridging methodology for a common validation of the molecular diagnosis value.
Magistrelli P; Neri M; Granone P; Cesario A; Paleari L; Russo P
Pancreas; 2008 Jul; 37(1):101-2. PubMed ID: 18580451
[No Abstract] [Full Text] [Related]
7. Shining the spotlight on shed KRAS in pancreatic cancer.
Sempere LF; Korc M
Cancer Biol Ther; 2008 Mar; 7(3):361-3. PubMed ID: 18614859
[No Abstract] [Full Text] [Related]
8. Long-term follow-up of patients with chronic pancreatitis and K-ras gene mutation detected in pancreatic juice.
Furuya N; Kawa S; Akamatsu T; Furihata K
Gastroenterology; 1997 Aug; 113(2):593-8. PubMed ID: 9247481
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance of K-ras and c-erbB-2 mutations in pancreatic adenocarcinoma and chronic pancreatitis.
Talar-Wojnarowska R; Gasiorowska A; Smolarz B; Romanowicz-Makowska H; Strzelczyk J; Janiak A; Kulig A; Malecka-Panas E
Int J Gastrointest Cancer; 2005; 35(1):33-41. PubMed ID: 15722572
[TBL] [Abstract][Full Text] [Related]
10. Genetic and epigenetic markers in the evaluation of pancreatic masses.
Ginestà MM; Mora J; Mayor R; Farré A; Peinado MA; Busquets J; Serrano T; Capellá G; Fabregat J
J Clin Pathol; 2013 Mar; 66(3):192-7. PubMed ID: 23135349
[TBL] [Abstract][Full Text] [Related]
11. LigAmp for sensitive detection of single-nucleotide differences.
Shi C; Eshleman SH; Jones D; Fukushima N; Hua L; Parker AR; Yeo CJ; Hruban RH; Goggins MG; Eshleman JR
Nat Methods; 2004 Nov; 1(2):141-7. PubMed ID: 15782177
[TBL] [Abstract][Full Text] [Related]
12. Molecular analysis of centrifugation supernatant fluid from pancreaticobiliary duct samples can improve cancer detection.
Finkelstein SD; Bibbo M; Loren DE; Siddiqui AA; Solomides C; Kowalski TE; Ellsworth E
Acta Cytol; 2012; 56(4):439-47. PubMed ID: 22846349
[TBL] [Abstract][Full Text] [Related]
13. Usefulness of p16 and K-ras mutation in pancreatic adenocarcinoma and chronic pancreatitis differential diagnosis.
Talar-Wojnarowska R; Gasiorowska A; Smolarz B; Romanowicz-Makowska H; Strzelczyk J; Janiak A; Kulig A; Malecka-Panas E
J Physiol Pharmacol; 2004 Jul; 55 Suppl 2():129-38. PubMed ID: 15608367
[TBL] [Abstract][Full Text] [Related]
14. Detection of Ki-ras oncogene mutations in pancreatic diseases: helpful or irrelevant?
Van Laethem JL
Acta Gastroenterol Belg; 1998; 61(3):295-7. PubMed ID: 9795456
[No Abstract] [Full Text] [Related]
15. [Ki-ras mutation as a molecular tumor marker for carcinoma of the pancreas].
Daus H; Trümper L; Bürger B; Jacobs G; Kriener S; von Blohn G; Zeitz M; Pfreundschuh M
Dtsch Med Wochenschr; 1995 Jun; 120(23):821-5. PubMed ID: 7781522
[TBL] [Abstract][Full Text] [Related]
16. Detection of mutations of p53 tumor suppressor gene in pancreatic juice and its application to diagnosis of patients with pancreatic cancer: comparison with K-ras mutation.
Yamaguchi Y; Watanabe H; Yrdiran S; Ohtsubo K; Motoo Y; Okai T; Sawabu N
Clin Cancer Res; 1999 May; 5(5):1147-53. PubMed ID: 10353750
[TBL] [Abstract][Full Text] [Related]
17. [Significance of ras mutations in pancreatic diseases].
Löhr M; Liebe S; Lowenfels AB
Z Gastroenterol; 1998 Oct; 36(10):929-32. PubMed ID: 9846373
[No Abstract] [Full Text] [Related]
18. Origin and prognostic value of circulating KRAS mutations in lung cancer patients.
Gautschi O; Huegli B; Ziegler A; Gugger M; Heighway J; Ratschiller D; Mack PC; Gumerlock PH; Kung HJ; Stahel RA; Gandara DR; Betticher DC
Cancer Lett; 2007 Sep; 254(2):265-73. PubMed ID: 17449174
[TBL] [Abstract][Full Text] [Related]
19. [Mutation of the K-ras oncogene in pancreatic carcinoma, and application of its detection in pancreatic juice to diagnose pancreatic carcinoma].
Sawabu N; Watanabe H; Yamaguchi Y; Okai T
Nihon Rinsho; 1995 Feb; 53(2):511-7. PubMed ID: 7699881
[TBL] [Abstract][Full Text] [Related]
20. The utility of Ki-ras mutation analysis in the cytologic diagnosis of pancreatobiliary neoplasma.
Dillon DA; Johnson CC; Topazian MD; Tallini G; Rimm DL; Costa JC
Cancer J; 2000; 6(5):294-301. PubMed ID: 11079168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
